Table 4. The association between genotype of rs2237051 and serum EGF.

Exposure	Non-adjusted	Model I	Model II
	β (95% CI)	β (95% CI)	β (95% CI)
Total
Genotype of rs2237051
AG/GG	Ref.	Ref.	Ref.
AA	3.06 [1.06–5.06]*	2.98 [0.98–4.98]*	2.86 [0.88–4.84]*
Healthy controls
Genotype of rs2237051
AG/GG	Ref.	Ref.	Ref.
AA	−0.33 [−3.41 to 2.76]	−0.22 [−3.32 to 2.89]	0.11 [−2.97 to 3.19]
GAgP patients
Genotype of rs2237051
AG/GG	Ref.	Ref.	Ref.
AA	5.10 [2.52–7.68]*	4.97 [2.35–7.59]*	4.70 [2.09–7.31]*

Notes:

^*P < 0.05, statistical significance.

Model I was adjusted for age and gender.

Model II was adjusted for age gender and BMI.

Data were presented as β (95% CI), outcome: serum EGF.

Exposure: genotype of rs2237051.